SCHEMBL4400758

SCHEMBL4400758

CCc1cnc2cc[nH]c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.44
APP P05067 1/20 0.41
PIK3C3 Q8NEB9 1/20 0.40
PARP1 P09874 2/20 0.35
PARP2 Q9UGN5 1/20 0.35
BRAF P15056 1/20 0.34
FGFR1 P11362 1/20 0.33
KDR P35968 1/20 0.33
IDO1 P14902 1/20 0.33
KIF11 P52732 1/20 0.33
MMP12 P39900 1/20 0.33
NOS3 P29474 1/20 0.32
NOS1 P29475 1/20 0.32
NOS2 P35228 1/20 0.32
SYK P43405 1/20 0.32
ALOX5AP P20292 1/20 0.32
FEN1 P39748 1/20 0.32
QPCT Q16769 1/20 0.32
KDM4E B2RXH2 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16774672 0.81 BRD4 (0.44) BRD4APPPIK3C3BRAFSYK
SCHEMBL19682171 0.81 BRD4 (0.41) BRD4APPPIK3C3BRAFFGFR1
SCHEMBL14637827 0.79 CDK8 (0.40) BRD4APPPIK3C3BRAFFGFR1
SCHEMBL14637826 0.79 BRD4 (0.39) BRD4APPPIK3C3BRAFFGFR1
SCHEMBL28215216 0.78 IDO1 (0.48) BRD4PIK3C3FGFR1IDO1
SCHEMBL28007340 0.76 FGFR1 (0.39) BRD4APPPIK3C3FGFR1KDR
SCHEMBL1150521 0.75 BRD4 (0.42) BRD4APPPIK3C3FGFR1MMP12
SCHEMBL586478 0.75 BRD4 (0.51) BRD4APPPIK3C3MMP12NOS3
SCHEMBL19751457 0.74 PDE3B (0.44) PARP1PARP2
SCHEMBL18123545 0.73 KCNH2 (0.39) PARP1NOS3NOS1NOS2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9884867-B2 Bicyclic alkyne derivatives and uses thereof AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2018-02-06 US disclosed
US-9139567-B2 Arylpyrazole ethers as inhibitors of leukotriene A4 hydrolase BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-09-22 US disclosed
US-20150252056-A1 BICYCLIC OXA-LACTAM KINASE INHIBITORS ALEXION PHARMACEUTICALS, INC. 2015-09-10 US disclosed
US-9096598-B2 Azaindoles as Janus kinase inhibitors MERCK SHARP & DOHME CORP. (US) 2015-08-04 US disclosed
US-20140303142-A1 AZAINDOLES AS JANUS KINASE INHIBITORS MERCK SHARP & DOHME LLC 2014-10-09 US disclosed
US-8802688-B2 Substituted acetyl-coa carboxylase inhibitors PFIZER INC. (US) 2014-08-12 US disclosed
US-20140221373-A1 ARYLPYRAZOLE ETHERS AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-08-07 US disclosed
WO-2013012844-A1 ARYLPYRAZOLE ETHERS AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-01-24 WO disclosed
US-20120329780-A1 Novel kinase inhibitors ORIGENIS GMBH (DE) 2012-12-27 US disclosed
US-20120270893-A1 SUBSTITUTED ACETYL-COA CARBOXYLASE INHIBITORS PFIZER INC. (US) 2012-10-25 US disclosed
US-8268871-B2 Mitotic kinesin inhibitors and methods of use thereof ARRAY BIOPHARMA INC. (US) 2012-09-18 US disclosed
US-20120108619-A1 N1/N2-LACTAM ACETYL-COA CARBOXYLASE INHIBITORS PFIZER INC 2012-05-03 US disclosed
US-20100331283-A1 Mitotic kinesin inhibitors and methods of use thereof ARRAY BIOPHARMA INC. (US) 2010-12-30 US disclosed
US-7795282-B2 Mitotic kinesin inhibitors and methods of use thereof ARRAY BIOPHARMA INC. (US) 2010-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150252056-A1 BICYCLIC OXA-LACTAM KINASE INHIBITORS SYK, BTK, JAK2 BRD4 601/4885APP 3608/4885PIK3C3 74/4885
US-20120108619-A1 N1/N2-LACTAM ACETYL-COA CARBOXYLASE INHIBITORS ACACA, ACACB, COASY BRD4 1413/4885APP 864/4885PIK3C3 4367/4885
US-20140303142-A1 AZAINDOLES AS JANUS KINASE INHIBITORS JAK1, JAK3, JAK2 BRD4 212/4885APP 4855/4885PIK3C3 186/4885
US-20120329780-A1 Novel kinase inhibitors LRRK2, MYLK2, MYLK BRD4 2023/4885APP 917/4885PIK3C3 811/4885
US-20100331283-A1 Mitotic kinesin inhibitors and methods of use thereof KIF5B, KIF2C, KIFC1 BRD4 811/4885APP 3451/4885PIK3C3 1345/4885
US-20140221373-A1 ARYLPYRAZOLE ETHERS AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE LTA4H, LTC4S, LTB4R BRD4 726/4885APP 2539/4885PIK3C3 2725/4885
US-20120270893-A1 SUBSTITUTED ACETYL-COA CARBOXYLASE INHIBITORS ACACA, ACACB, ACAT1 BRD4 766/4885APP 2062/4885PIK3C3 3926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.